Saturable Metabolism and its Relationship to Toxicity

References

• Segel I.H. Enzyme Kinetics—Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley & Sons, New York 1975
   Google Scholar
• Brown A.C. Passive and active transport, in Physiology and Biophysics19th ed., CT. Ruch, DH. Patton. W. B. Saunders, Philadelphia 1966, chap. 43
   Google Scholar
• Rennick B.A. Renal excretion of drugs: tubular transport and metabolism. Annu. Rev. Pharmacol. 1972; 12: 141
   PubMedGoogle Scholar
• Edsall J.T. Blood and hemoglobin: the evolution of knowledge of functional adaptation in a biochemical system. I. The adaptation of chemical structure to function in hemoglobin. J. Hist. Biol. 1972; 5: 205
   PubMedGoogle Scholar
• Michaelis L., Menten M.L. Die Kinetik der Invertinwirkung. Biochem. Z. 1913; 49: 333
   Google Scholar
• Sumner J.B. The isolation and crystallization of the enzyme urease. Preliminary paper. J. Biol. Chem. 1926; 69: 435
   Google Scholar
• Moore W.J. chap. 8. Physical Chemistry3rd ed. Englewood Cliffs, Prentice-Hall 1962, New Jersey
   Google Scholar
• Riggs D.S. The Mathematical Approach to Physiological Problems. The MIT Press, Cambridge, Mass. 1963; 272
   Google Scholar
• Mahler H.R., Cordes E.H. Biological Chemistry. Harper & Row, New York 1966, chap. 6
   Google Scholar
• Laidler K., Bunting P.S. The Chemical Kinetics of Enzyme Action2nd ed. Clarendon Press, Oxford 1973
   Google Scholar
• Kappas A., Alvares A.P. How the liver metabolizes foreign substances. Sci. Am. 1975; 232: 22
   PubMed Web of Science ®Google Scholar
• Fundamentals of Drug Metabolism and Disposition, B.N. La Du, H.G. Mandel, E.L. Way. Williams & Wilkins, Baltimore 1971
   Google Scholar
• Testa B., Jenner P. Drug Metabolism: Chemical and Biochemical Aspects. Marcel Dekker, New York 1976
   Google Scholar
• Rosenoer V.M., Tornay A.S. Drugs and the liver. Med. Clinics N. Am. 1979; 63: 405
   PubMed Web of Science ®Google Scholar
• Koch A. The kidney. Physiology and Biophysics19th ed., T.C. Ruch, H.D. Patton. W. B. Saunders, Philadelphia 1966, chap. 44
   Google Scholar
• Levine W.G. Biliary excretion of drugs and other xenobiotics. Annu. Rev. Pharmacol. Toxicol. 1978; 18: 81
   PubMed Web of Science ®Google Scholar
• Williams R.T. Inter-species variations in the metabolism of xenobiotics. Biochem. Soc. Trans. 1974; 2: 359
   Google Scholar
• Thorgeirsson S.S., Wirth P.J. Genetic aspects of metabolic processing of chemical substances. J. Toxicol. Environ. Health 1979; 5: 83
   PubMed Web of Science ®Google Scholar
• Magee P.N. Activation and inactivation of chemical carcinogens and mutagens in the mammal. Essays in Biochemistry 1974; 10: 105
   PubMedGoogle Scholar
• Eger E.I. II, Inhalational anesthesia: pharmacokinetics. General Anesthesia, T.C. Gray, J.F. Nunn. Butterworths, London 1971; Vol. 1, chap. 30
   Google Scholar
• Eger E.I. Uptake distribution, and elimination of inhaled anesthetics. Scientific Foundations of Anesthesia, C. Scurr, S. Freeman. Year Book Medical Publishing, Chicago 1974, chap. 3
   Google Scholar
• Dinman B.K. The mode of entry and action of toxic materials. Patty's Industrial Hygiene and Toxicology3rd ed. John Wiley & Sons, New York 1978; Vol. 1, chap. 6
   Google Scholar
• Withey J.R. Pharmacodynamics and uptake of vinyl chloride monomer administered by various routes to rats. J. Toxicol. Environ. Health 1976; 1: 381
   PubMed Web of Science ®Google Scholar
• Bolt H.M., Laib R.J., Kappus H., Buchter A. Pharmacokinetics of vinyl chloride in the rat. Toxicology 1977; 7: 179
   PubMed Web of Science ®Google Scholar
• Bolt H.M. Pharmacokinetics of vinyl chloride. Gen. Pharmacol. 1978; 9: 91
   PubMedGoogle Scholar
• Irish D.D. Halogenated hydrocarbons. I. Aliphatic. Industrial Hygiene and Toxicology2nd ed., F.A. Patty. Interscience, New York 1963; Vol. II, chap. 31
   Google Scholar
• Maltoni C., Lefemine G. Carcinogenicity bioassays of vinyl chloride: current results. Ann. N. Y. Acad. Sci. 1975; 246: 195
   PubMed Web of Science ®Google Scholar
• Maltoni C., Lefemine G. Carcinogenicity bioassays of vinyl chloride. I. Research plan and early results. Environ. Res. 1974; 7: 387
   Web of Science ®Google Scholar
• Maltoni C. The value of predictive experimental bioassays in occupational and environmental carcinogenesis. An example: vinyl chloride. Ambio 1975; 4: 18
   Google Scholar
• Creech J.L., Jr., Johnson M.N. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J. Occup. Med. 1974; 16: 150
   PubMedGoogle Scholar
• Heath C.W., Jr., Falk H., Creech J.L., Jr. Characteristics of cases of angiosarcoma of the liver among vinyl chloride workers in the United States. Ann. N. Y. Acad. Sci. 1975; 246: 231
   PubMed Web of Science ®Google Scholar
• Greim H., Bonse G., Radwan Z., Reichert D., Henschler D. Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxirane formation. Biochem Pharmacol. 1975; 24: 2013
   PubMed Web of Science ®Google Scholar
• Malaveille C., Bartsch H., Barbin A., Camus A.M., Montesano R. Mutagenicity of vinyl chloride, chloroethyleneoxide, chloroacetaldehyde and chloroethanol. Biochem. Biophys. Res. Commun. 1975; 63: 363
   PubMed Web of Science ®Google Scholar
• Bartsch H., Malaveille C., Montesano R. Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. Typhimurium strains. Int. J. Cancer 1975; 15: 429
   PubMed Web of Science ®Google Scholar
• Bartsch H., Malaveille C., Barbin A., Bresil H., Tomatis L., Montesano R. Mutagenicity and metabolism of vinyl chloride and related compounds. Environ. Health Perspect. 1976; 17: 193
   PubMed Web of Science ®Google Scholar
• Henschler D. Metabolism and mutagenicity of halogenated olefins—a comparison of structure and activity. Environ. Health Perspect. 1977; 21: 61
   PubMed Web of Science ®Google Scholar
• van Duuren B.L. On the possible mechanism of carcinogenic action of vinyl chloride. Ann. N. Y. Acad. Sci. 1975; 246: 258
   PubMed Web of Science ®Google Scholar
• Hathway D.E. Comparative mammalian metabolism of vinyl chloride and vinylidene chloride in relation to oncogenic potential. Environ. Health Perspect. 1977; 21: 55
   PubMed Web of Science ®Google Scholar
• Kappus H., Bolt H.M., Buchter A., Bolt W. Rat liver microsomes catalyze covalent binding of14 C-vinyl chloride to macromolecules. Nature (London) 1975; 257: 134
   PubMed Web of Science ®Google Scholar
• Kappus H., Bolt H.M., Buchter A., Bolt W. Liver microsomal uptake of [14 C] vinyl chloride and transformation to protein alkylating metabolites in vitro. Toxicol. Appl. Pharmacol. 1976; 37: 461
   PubMed Web of Science ®Google Scholar
• Green T., Hathway D.E. The biological fate in rats of vinyl chloride in relation to its oncogenicity. Chem. Biol. Interact. 1975; 11: 542
   Web of Science ®Google Scholar
• Hefner R.E., Jr., Watanabe P.G., Gehring P.J. Preliminary studies on the fate of inhaled vinyl chloride monomer in rats. Ann. N. Y. Acad. Sci. 1975; 246: 135
   Web of Science ®Google Scholar
• Watanabe P.G., McGowan G.R., Madrid E.O., Gehring P.J. Fate of14 C-vinyl chloride following inhalation exposure in rats. Toxicol. Appl. Pharmacol. 1976; 37: 49
   PubMed Web of Science ®Google Scholar
• Watanabe P.G., McGowan G.R., Gehring P.J. Fate of14 C-vinyl chloride after single oral administration in rats. Toxicol. Appl. Pharmacol. 1976; 36: 339
   PubMed Web of Science ®Google Scholar
• Gillette J.R., Mitchell J.R., Brodie B.B. Biochemical mechanisms of drug toxicity. Annu. Rev. Pharmacol. 1974; 14: 271
   Google Scholar
• Watanabe P.G., Hefner R.E., Jr., Gehring P.J. Vinyl chloride-induced depression of hepatic non-protein sulfhydryl content and effects on bromosulphalein (BSP) clearance in rats. Toxicology 1976; 6: 1
   PubMed Web of Science ®Google Scholar
• Watanabe P.G., Zempel J.A., Pegg D.G., Gehring P.J. Hepatic macromolecular binding following exposure to vinyl chloride. Toxicol. Appl. Pharmacol. 1978; 44: 571
   PubMed Web of Science ®Google Scholar
• Gehring P.J., Watanabe P.G., Park C.N. Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example—vinyl chloride. Toxicol. Appl. Pharmacol. 1978; 44: 581
   PubMed Web of Science ®Google Scholar
• National Cancer Institute, Carcinogenesis Bioassay of Trichloroethylene. NCI Carcinogen. Tech. Rep. Ser. No. 2. U.S. Department of Health, Education and Welfare, Bethesda, MD 1976, NCI-CG-TR-2, Publ. No. (NIH) 76–802
   Google Scholar
• Watanabe P.G., Zempel J.A., Gehring P.J. Comparison of the fate of vinyl chloride following single and repeated exposure in rats. Toxicol. Appl. Pharmacol. 1978; 44: 391
   PubMed Web of Science ®Google Scholar
• Jaeger R.J., Reynolds E.S., Conolly R.B., Moslen M.T., Szabo S., Murphy S.D. Acute hepatic injury by vinyl chloride in rats pretreated with phenobarbital. Nature (London) 1974; 252: 724
   PubMed Web of Science ®Google Scholar
• Reynolds E.S., Moslen M.T., Szabo S., Jaeger R.J., Murphy S.D. Hepatotoxicity of vinyl chloride and 1,1-dichloroethylene. Exp. Mol. Pathol. 1975; 81: 219
   Google Scholar
• Conolly R.B., Jaeger R.J. Acute hepatotoxicity of ethylene and halogenated ethylenes after PCB pretreatment. Environ. Health Perspect. 1977; 21: 131
   PubMed Web of Science ®Google Scholar
• Reynolds E.S., Moslen M.T. Damage to hepatic cellular membranes by chlorinated olefins with emphasis on synergism and antagonism. Environ. Health Perspect. 1977; 21: 137
   PubMed Web of Science ®Google Scholar
• Reynolds E.S., Moslen M.T., Boor P.J., Bailey K., Szabo S. Trichloroethylene-induced deactivation of liver endoplasmic reticulum and glutathione depletion. Toxicol. Appl. Pharmacol 1977; 41: 217
   Web of Science ®Google Scholar
• Moslen M.T., Reynolds E.S., Szabo S. Enhancement of the metabolism and hepatotoxicity of trichloroethylene and perchloroethylene. Biochem. Pharmacol. 1977; 26: 369
   PubMed Web of Science ®Google Scholar
• Jenkins L.J., Jr., Trabulus M.J., Murphy S.D. Biochemical effects of 1,1-dichloroethylene in rats: comparison with carbon tetrachloride and 1,2-dichloroethylene. Toxicol. Appl. Pharmacol. 1972; 23: 501
   PubMed Web of Science ®Google Scholar
• Jaeger R.J., Conolly R.B., Murphy S.D. Effect of 18 hr fast and glutathione depletion on 1,1-dichloroethylene-induced hepatotoxicity and lethality in rats. Exp. Mol. Pathol. 1974; 20: 187
   PubMed Web of Science ®Google Scholar
• Andersen M.E., Jenkins L.J., Jr. Oral toxicity of 1,1-dichloroethylene in the rat: effects of sex, age, and fasting. Environ. Health Perspect. 1977; 21: 157
   PubMed Web of Science ®Google Scholar
• Jaeger R.J., Conolly R.B., Murphy S.D. Diurnal variation of hepatic glutathione concentration and its correlation with 1,1-dichloroethylene inhalation toxicity in rats. Res. Commun. Chem. Pathol. Pharmacol. 1973; 6: 465
   PubMedGoogle Scholar
• McKenna M.J., Zempel J.A., Madrid E.O., Gehring P.J. The pharmacokinetics of [14C] vinylidene chloride in rats following inhalation exposure. Toxicol. Appl. Pharmacol 1978; 45: 599
   PubMed Web of Science ®Google Scholar
• McKenna M.J., Zempel J.A., Madrid E.O., Braun W.H., Gehring P.J. Metabolism and pharmacokinetic profile of vinylidene chloride in rats following oral administration. Toxicol. Appl. Pharmacol. 1978; 45: 821
   PubMed Web of Science ®Google Scholar
• McKenna M.J., Watanabe P.G., Gehring P.J. Pharmacokinetics of vinylidene chloride in the rat. Environ. Health Perspect. 1977; 21: 99
   PubMed Web of Science ®Google Scholar
• Bartsch H., Malaveille C., Montesano R., Tomatis L. Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene. Salmonella typhimurium. Nature, (London) 1975; 255: 641
   Google Scholar
• Irish D.D. Halogenated hydrocarbons: I. Aliphatic. Industrial Hygiene and Toxicology2nd ed., D.W. Fasset, D.D. Irish. Interscience, New York 1963; Vol. 2: 1305
   Google Scholar
• Andersen M.E., Gargas M.L., Jones R.A., Jenkins L.J., Jr. The use of inhalation techniques to assess the kinetic constants of 1,1-dichloroethylene metabolism. Toxicol. Appl. Pharmacol. 1979; 47: 395
   PubMed Web of Science ®Google Scholar
• Andersen M.E., French J.E., Gargas M.L., Jones R.A., Jenkins L.J., Jr. Saturable metabolism and the acute toxicity of 1,1-dichloroethylene. Toxicol. Appl. Pharmacol. 1979; 47: 385
   PubMed Web of Science ®Google Scholar
• Filser J.G., Bolt H.M. Pharmacokinetics of halogenated ethylenes in rats. Arch. Toxicol 1979; 42: 123
   PubMed Web of Science ®Google Scholar
• Jaeger R.J., Shoner L.G., Coffman L. 1,1-Dichloroethylene hepatotoxicity: proposed mechanism of action and distribution and binding of14C radioactivity following inhalation exposure in rats. Environ. Health Perspect. 1977; 21: 113
   PubMed Web of Science ®Google Scholar
• Andersen M.E., Gargas M.L., Jones R.A., Jenkins L.J., Jr. Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements. Toxicol. Appl. Pharmacol 1980; 54: 100
   PubMed Web of Science ®Google Scholar
• Gargas M.L., Andersen M.E. Metabolism of inhaled brominated hydrocarbons: validation of gas uptake results by direct determination of a stable metabolite. Toxicol. Appl. Pharmacol., in review
   Google Scholar
• World Health Organization, Inhalation exposure. Environmental Health Criteria 6, Principles and Methods for Evaluating the Toxicity of Chemicals, Part I. Geneva 1978, chap. 6
   Google Scholar
• Gargas M.L., Andersen M.E., Jenkins L.J., Jr. Metabolism of inhaled organic bromides: corroboration of gas uptake results by direct measurement of inorganic bromide production. 19th Annu. Meet. of the Soc. of Toxicol. Washington, DC March, 1980, Abstract no. 118
   Google Scholar
• Gargas M.L., Andersen M.E. Closed atmosphere gas uptake studies and their validation by direct metabolite determination. Proc. 10th Annu. Conf. Environ. Toxicol. Wright-Patterson Air Force Base, Ohio 1980; 74, AFAMRL-TRR-79–121
   Google Scholar
• Bliss C.I. The method of probits. Science 1934; 79: 38
   PubMed Web of Science ®Google Scholar
• Litchfield J.T., Jr., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949; 96: 99
   PubMed Web of Science ®Google Scholar
• Gaddum J.H. Bioassays and mathematics. Pharmacol. Rev. 1953; 5: 87
   PubMed Web of Science ®Google Scholar
• Weil C.S. Tables for convenient calculation of the median effective dose (LD50 or ED50) and instruction in their use. Biometrics 1952; 8: 249
   Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Drugs and the pharmaceutical sciences. Pharmacokinetics. Marcel Dekker, New York 1975; Vol. 1, chap. 7
   Google Scholar
• McKenna M.J., Zempel J.A., Braun W.H. The pharmacokinetics of inhaled methylene chloride in rats. Proc. 9th Annu. Conf. Environ. Toxicol. Wright-Patterson Air Force Base, Ohio 1979; 183, AMRL-TR-79–68
   Google Scholar
• Stewart R.D., Fisher T.N., Hosko M.J., Peterson J.E., Baretta E.D., Dodd H.C. Carboxyhemoglobin elevation after exposure to dichloromethane. Science 1972; 176: 295
   PubMed Web of Science ®Google Scholar
• Di Vincenzo D.G., Hamilton M.L. Fate and disposition of [14C] methylene chloride in the rat. Toxicol. Appl. Pharmacol. 1975; 32: 385
   PubMed Web of Science ®Google Scholar
• Kubic V.L., Anders M.W. Metabolism of dihalomethanes to carbon monoxide. Drug Metab. Dispos. 1972; 3: 104
   Google Scholar
• Anders M.W., Kubic V.L., Ahmed A.E. Metabolism of halogenated methanes and macromolecular binding. J. Environ. Pathol. Toxicol. 1977; 1: 117
   PubMedGoogle Scholar
• Rodkey F.L., Collison H.A. Biological oxidation of [14C] methylene chloride to carbon monoxide and carbon dioxide by the rat. Toxicol. Appl. Pharmacol. 1978; 40: 33
   Web of Science ®Google Scholar
• Rodkey F.L., Collison H.A. Effect of dihalogenated methanes on the in vivo production of carbon monoxide and methane by rats. Toxicol. Appl. Pharmacol. 1977; 40: 39
   PubMed Web of Science ®Google Scholar
• Stewart R.D. The effect of carbon monoxide on humans. Annu. Rev. Pharmacol. 1975; 15: 409
   PubMedGoogle Scholar
• Putz V.E., Johnson B.L., Setzer J.V. A comparative study of the effects of CO and CH2CL2 on human performance. J. Environ. Pathol. Toxicol. 1979; 2: 97
   PubMedGoogle Scholar
• National Institute of Occupational Safety and Health, Vinyl halides carcinogenicity. NIOSH/OSHA Current Intelligence Bulletin 28. U.S. Department of Health, Education and Welfare, Bethesda, MD 1979, (NIOSH) Publ. No. 79–102
   Google Scholar
• Bolt H.M., Filser J.G., Hinderer R.K. Rat liver microsomal uptake and irreversible protein binding of [1,2-14C] vinyl bromide. Toxicol. Appl. Pharmacol. 1978; 44: 481
   PubMed Web of Science ®Google Scholar
• Sato A., Nakajima T. A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicol. Appl. Pharmacol. 1979; 47: 41
   PubMed Web of Science ®Google Scholar
• Sato A., Nakajima T. Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro. Toxicol. Appl. Pharmacol. 1979; 48: 249
   PubMed Web of Science ®Google Scholar
• Snyder R., Kocsis J.J. Current concepts of chronic benzene toxicity. CRC Crit. Rev. Toxicol. 1975; 3: 265
   PubMedGoogle Scholar
• Hilderbrand R.L., Andersen M.E., Jenkins L.J., Jr. Metabolism of inhaled benzene and toluene: correlation between kinetic constants obtained in vivo and in vitro. 19th Annu. Meet. Soc. Toxicol. Washington, DC March, 1980, Abstract no. 175
   Google Scholar
• Andersen M.E. Physiological factors important in controlling the metabolism of inhaled gases and vapors. Proc. 10th Annu. Conf. Environ. Toxicol. Wright-Patterson Air Force Base, Ohio 1979; 118, AF-AMRL-TR-79–121
   Google Scholar
• Wilkinson G.R., Shand D.G. Commentary. A physiological approach to drug clearance. Clin. Pharmacol. Ther. 1975; 18: 377
   PubMed Web of Science ®Google Scholar
• Pang K.S., Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel-tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm. 1977; 5: 625
   PubMedGoogle Scholar
• Rowland M. Influence of route of administration on drug availability. J. Pharm. Sci. 1972; 61: 70
   PubMed Web of Science ®Google Scholar
• Goldstein A., Aronow L., Kalman S.M. Principles of Drug Action: The Basis of Pharmacology2nd ed. John Wiley & Sons, New York 1974; 212
   Google Scholar
• Brauer R.W. Liver circulation and function. Physiol. Rev. 1963; 43: 115
   PubMed Web of Science ®Google Scholar
• Andersen M.E. A physiologically based pharmacokinetic description of the metabolism of inhaled gases and vapors: analysis at steady-state. Toxicol. Appl. Pharmacol., in review
   Google Scholar
• Andersen M.E. Organ perfusion as the rate limiting step in the metabolism of some inhaled gases and vapors. 19th Annu. Meet. Soc. Toxicol. Washington, DC March, 1980, Abstract no. 177
   Google Scholar
• Pang K.S., Rowland M., Tozer T.N. In vivo evaluation of Michaelis-Menten constants of drug-eliminating systems. Drug Metab. Dispos. 1978; 6: 197
   PubMed Web of Science ®Google Scholar
• Routledge P.A., Shand D.G. Presystemic drug elimination. Annu. Rev. Pharmacol. Toxicol. 1979; 19: 447
   PubMed Web of Science ®Google Scholar
• Combes B., Wheeler H.O., Childs A.W., Bradley S.E. The mechanisms of bromsulfalein removal from the blood. Trans. Assoc. Am. Physicians 1956; 69: 276
   PubMedGoogle Scholar
• Fernandez J.G., Droz P.O., Humbert B.E., Caperos J.R. Trichloroethylene exposure. Simulation of uptake, excretion and metabolism using a mathematical model. Br. J. Ind. Med. 1977; 34: 43
   PubMedGoogle Scholar
• Sato A., Nakajima T., Fujiwara Y., Murayama N. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br. J. Ind. Med. 1977; 34: 56
   PubMedGoogle Scholar
• Sato A., Nakajima T. Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Br. J. Ind. Med. 1979; 36: 231
   PubMedGoogle Scholar
• Guillemin M.P., Bauer D. Biological monitoring of exposure to styrene by analysis of combined urinary mandelic and phenyglyoxylic acids. Am. Hyg. Assoc. J. 1978; 39: 873
   PubMed Web of Science ®Google Scholar
• Fields R.L., Horstman S.W. Biomonitoring of industrial styrene exposures. Am. Ind. Hyg. Assoc. J. 1979; 40: 451
   PubMed Web of Science ®Google Scholar
• Sato A., Nakajima T. A structure-activity relationship of some chlorinated hydrocarbons. Arch. Environ. Health 1979; 34: 69
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V., Holaday D. Uptake and clearance of inhalation anesthetics in man. Drug Metab. Rev. 1979; 9: 43
   PubMed Web of Science ®Google Scholar
• Holaday D., Fiserova-Bergerova V. Fate of fluorinated metabolites of inhalation anesthetics in man. Drug Metab. Rev. 1979; 9: 61
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V. Simulation of uptake, distribution, metabolism and excretion of lipid soluble solvents in man. Proc. 3rd Annu. Conf. Environ. Toxicol. Wright-Patterson Air Force Base, Ohio 1972; 53, AMRL-TR-72–130
   Google Scholar
• Fiserova-Bergerova V. Modeling of chronic toxicity. J. Combust. Toxicol. 1976; 3: 201
   Google Scholar
• Fiserova-Bergerova V., Vlach J., Singhal K. Simulation and prediction of uptake, distribution, and exhalation of organic solvents. Br. J. Ind. Med. 1974; 31: 45
   PubMedGoogle Scholar
• Gillette J.R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 1974; 23: 2785
   PubMed Web of Science ®Google Scholar
• Gillette J.R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding. Biochem. Pharmacol. 1974; 23: 2927
   PubMed Web of Science ®Google Scholar
• Daly J.W., Jerina D.M., Witkop B. Arene oxides and the NIH shift. The metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 1972; 28: 1129
   PubMedGoogle Scholar
• Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151
   PubMed Web of Science ®Google Scholar
• Levy G. Pharmacokinetics of salicylate in man. Drug Metab. Rev. 1979; 9: 3
   PubMed Web of Science ®Google Scholar
• Arnold K., Gerber N. The rate of decline of diphenylhydantoin in human plasma. Clin. Pharmacol. Ther. 1970; 11: 121
   PubMed Web of Science ®Google Scholar
• Lundquist F., Wolthers H. The kinetics of alcohol elimination in man. Acta Pharmacol. Toxicol. 1968; 14: 265
   Google Scholar
• Young J.D., Braun W.H., Gehring P.J. Dose-dependent fate of 1,4-dioxane in rats. J. Toxicol. Environ. Health 1978; 4: 709
   PubMed Web of Science ®Google Scholar
• Argus M.F., Arcos J.C., Hoch-Ligeti C. Studies on the carcinogenic activity of protein-denaturing agents: hepatocarcinogenicity of dioxane. J. Natl. Cancer Inst. 1965; 35: 949
   PubMed Web of Science ®Google Scholar
• Hoch-Ligeti C., Argus M.F., Arcos J.C. Induction of carcinomas in the nasal cavity of rats by dioxane. Br. J. Cancer 1970; 24: 164
   PubMed Web of Science ®Google Scholar
• Argus M.F., Sohal R.S., Bryant G.M., Hoch-Ligeti C., Arcos J.C. Dose-response and ultrastructural alterations in dioxane carcinogenesis. Eur. J. Cancer 1973; 9: 237
   PubMed Web of Science ®Google Scholar
• Kociba R.J., McCollister S.B., Park C., Torkleson T.R., Gehring P.J. 1,4-Dioxane. I. Results of a 2-year ingestion study in rats. Toxicol. Appl. Pharmacol. 1974; 30: 275
   Web of Science ®Google Scholar
• Young J.D., Braun W.H., Rampy L.W., Chenoweth M.B., Blau G.E. Pharmacokinetics of 1,4-dioxane in humans. J. Toxicol. Environ. Health 1977; 3: 507
   PubMed Web of Science ®Google Scholar
• Pang K.S., Gillette J.R. Complications in the estimation of hepatic blood flow in vivo by pharmacokinetic parameters: the area under the curve after the concomitant intravenous and intraperitoneal (or intraportal) administration of acetaminophen in the rat. Drug Metab. Dispos. 1978; 6: 567
   Web of Science ®Google Scholar
• Sauerhoff M.W., Braun W.H., Blau G.E., Gehring P.J. The dose-dependent pharmacokinetic profile of 2,4,5-trichlorophenoxy acetic acid following intravenous administration to rats. Toxicol. Appl. Pharmacol. 1976; 36: 491
   PubMed Web of Science ®Google Scholar
• Wagner J.G. Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics. J. Pharmacokinet. Biopharm. 1973; 1: 103
   PubMedGoogle Scholar
• Sauerhoff M.W., Braun Le W.H., Beau J.E. Dose-dependent pharmacokinetic profile of silvex following intravenous administration in rats. J. Toxicol. Environ. Health 1977; 2: 605
   PubMed Web of Science ®Google Scholar
• Rowe V.K., Hymas T.A. Summary of toxicological information of 2,4-D and 2,4,5-T herbicides and evaluation of the hazards to livestock associated with their use. Am. J. Vet. Res. 1954; 15: 622
   PubMed Web of Science ®Google Scholar
• Ramsey J.C., Young J.D. Comparative pharmacokinetics of inhaled styrene in rats and humans. Proc. 10th Annu. Conf. Environ. Toxicol. Wright-Patterson Air Force Base, Ohio 1980; 103, AFAMRL-TR-79–121
   Google Scholar
• Withey J.R., Collins P.G. Pharmacokinetics and distribution of styrene monomer in rats after intravenous administration. J. Toxicol. Environ. Health 1977; 3: 1011
   PubMed Web of Science ®Google Scholar
• Ramsey J.C., Young J.D. Pharmacokinetics of inhaled styrene in rats and humans. Scand. J. Work Environ. Health 1978; 4: 84, Suppl. 2
   PubMed Web of Science ®Google Scholar
• Atkinson A.J., Jr., Kushner W. Clinical pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 1979; 19: 105
   PubMed Web of Science ®Google Scholar
• Wagner J.G. Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics. J. Pharmacokinet. Biopharm. 1978; 6: 209
   PubMedGoogle Scholar
• Lam G., Chou W.L. Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics. J. Pharmacokinet. Biopharm. 1979; 7: 227
   PubMedGoogle Scholar
• Hiles R.A., Birch C.G. Nonlinear metabolism and disposition of 3,4,4′-trichlorocarbanilide in the rat. Toxicol. Appl. Pharmacol. 1978; 46: 323
   PubMed Web of Science ®Google Scholar
• Environmental Protection Agency draft, Oncogenicity testing standards (June 1978). Chem. Regul. Rep. 1978; 2: 466
   Google Scholar
• Vaughan R.W., Sipes I.G., Brown B.R., Jr. Minireview: role of biotransformation in the toxicity of inhalation anesthetics. Life Sci. 1978; 23: 2447
   PubMed Web of Science ®Google Scholar
• Roth R.A., Wiersma D.A. Role of the lung in total body clearance of circulating drugs. Clin. Pharmacokin. 1979; 4: 355
   PubMed Web of Science ®Google Scholar
• Adolph E.F. Quantitative relations in the physiological constitutions of mammals. Science 1949; 109: 579
   PubMed Web of Science ®Google Scholar
• Guyton A.C. Respiratory volumes of laboratory animals. Am. J. Physiol 1947; 150: 70
   PubMed Web of Science ®Google Scholar
• Respiration and circulation. Fed. Am. Soc. Exp. Biol, P.L. Altman, D.S. Dittmer, Bethesda, MD 1971
   Google Scholar
• Harrison L.I., Gibaldi M. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. J. Pharm. Sci. 1977; 66: 1138
   PubMed Web of Science ®Google Scholar
• Bischoff K.B., Dedrick R.L., Zaharko D.S., Longstreth J.A. Methotrexate pharmacokinetics. J. Pharm. Sci. 1971; 60: 1128
   PubMed Web of Science ®Google Scholar
• Himmelstein K.J., Lutz R.J. A review of the applications of physiologically based pharmacokinetic modeling. J. Pharmacokinet. Biopharm. 1979; 7: 127
   PubMedGoogle Scholar
• Dedrick R.L. Animal scale-up. J. Pharmacokinet. Biopharm. 1973; 1: 435
   PubMedGoogle Scholar
• Dedrick R.L., Bischoff K.B. Species similarities in pharmacokinetics. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1980; 39: 54
   PubMedGoogle Scholar
• Rane A., Wilkinson G.R., Shand G. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. J. Pharmacol. Exp. Ther. 1977; 200: 420
   PubMed Web of Science ®Google Scholar
• Wiersma D.A., Roth R.A. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance. J. Pharmacol. Exp. Ther. 1980; 212: 97
   PubMed Web of Science ®Google Scholar
• Junod A.F. Uptake, metabolism and efflux of14C-5-hydroxytryptamine in isolated perfused rat lung. J. Pharmacol. Exp. Ther. 1972; 183: 341
   PubMed Web of Science ®Google Scholar
• Hilderbrand R.L., Andersen M.E. Prediction of in vivo kinetic constants for metabolism of inhaled vapors from kinetic constants measured in vitro. Fund. Appl. Toxicol., in review
   Google Scholar
• Yih T.D., Rossum J.M. Isolated rat hepatocytes and 9000 g rat liver supernatant as metabolic systems for the study of the pharmacokinetics of barbiturates. Xenobiotica 1977; 7: 753
   Web of Science ®Google Scholar
• Grundin R., Moldeus P., Orrenius S., Borg K.O., Von Skanberg I., Bahr C. The possible role of cytochrome P-450 in the liver “first pass elimination” of a β-receptor blocking drug. Acta Pharmacol. Toxicol. 1974; 35: 242
   PubMedGoogle Scholar
• Pang K.S., Gillette J.R. Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary. Drug Melab. Dispos. 1980; 8: 39
   PubMed Web of Science ®Google Scholar
• Pang K.S., Gillette J.R. Sequential first-pass elimination of a metabolite derived from a precursor. J. Pharmacokinet. Biopharm. 1979; 7: 275
   PubMedGoogle Scholar
• James R.C., Franklin M.R. Tissue concentrations and the mortality of d-amphetamine in mice: changes associated with the use of diethylaminoethyl 2,2-diphenylvalerate-HCI. Toxicol. Appl. Pharmacol. 1978; 44: 75
   PubMed Web of Science ®Google Scholar
• James R.C., Franklin M.R. The triphasic amphetamine lethal dose curve in mice and its possible relationship to drug metabolism. Toxicol. Appl. Pharmacol. 1978; 44: 63
   PubMed Web of Science ®Google Scholar
• Wilkinson G.R. Pharmacokinetics of drug disposition: hemodynamic considerations. Annu. Rev. Pharmacol. 1975; 15: 11
   PubMedGoogle Scholar
• McKenna M.J. 1980, personal communication
   Google Scholar